Achieving HCV Elimination in the United States: Progress and Next Steps

HCV Elimination 2019 Program Image
Expert faculty explore the necessary steps to achieve HCV elimination in this online educational program. Choose from 3 interactive CME/CE-certified video modules, 6 CME/CE-certified Webinars with accompanying downloadable audio and slidesets, and 3 ClinicalThought commentaries that disuss best practices in patient management for specific populations that are essential if HCV elimination is to be a feasible goal.
Mark S. Sulkowski, MD
Program Director
Daniel Fierer Headshot
Daniel S. Fierer, MD
W. David Hardy, MD
Arthur Kim, MD
Christian B. Ramers, MD, MPH
Jeannette M. Tetrault, MD, FACP, FASAM

Video Modules

This CME/CE-certified interactive video module provides in-depth expert perspectives on critical barriers impeding the diagnosis, treatment, and cure of HCV infection among persons who inject drugs along with an analysis of critical strategies for overcoming these challenges to address both HCV and other important healthcare needs of this vulnerable population.

Mark S. Sulkowski, MD
Program Director
Arthur Kim, MD Christian B. Ramers, MD, MPH Jeannette M. Tetrault, MD, FACP, FASAM
Physicians: maximum of 1.75 AMA PRA Category 1 Credits Registered Nurses: 1.7 Nursing contact hours Pharmacists: 1.75 contact hours (0.175 CEUs) Released: April 2, 2019 Expiration: April 1, 2020

This CME/CE-certified interactive video module provides in-depth expert perspectives on barriers impeding expanded treatment and cure of HCV infection among men who have sex with men along with an analysis of critical strategies for preventing HCV infection and promoting sexual health.

Mark S. Sulkowski, MD
Program Director
Daniel Fierer Headshot Daniel S. Fierer, MD W. David Hardy, MD
Physicians: maximum of 2.0 AMA PRA Category 1 Credits Registered Nurses: 1.9 Nursing contact hours Pharmacists: 2.0 contact hours (0.2 CEUs) Released: April 16, 2019 Expiration: April 15, 2020

Downloadable Slideset

This downloadable slideset provides an in-depth review of strategies for overcoming barriers to the elimination of HCV infection among persons who inject drugs.

Arthur Kim, MD Christian B. Ramers, MD, MPH Jeannette M. Tetrault, MD, FACP, FASAM Released: April 2, 2019
Jointly provided by

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

This activity is supported by an independent educational grant from
AbbVie
Gilead Sciences

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?